Statins Linked to Lower Glaucoma Risk

Adults over 40 who take statins showed reduced glaucoma risk and fewer eye procedures in a large observational study.

Updated on Nov. 3, 2026 in Stroke

Photograph of a brass slit-lamp microscope on a pale clinical examination table, lit by soft window light, suggesting eye care.
A new study in the British Journal of Ophthalmology found adults over 40 who take statins had a lower risk of glaucoma and fewer eye procedures. AI Illustration. Upload story photo >

A new study in the British Journal of Ophthalmology found that people taking statins, a common cholesterol-lowering drug class, have a lower risk of developing glaucoma. Among glaucoma patients, statin users also needed fewer eye procedures and daily pressure-lowering eye drops.

Why it matters

Glaucoma remains the leading cause of irreversible blindness worldwide, so any modifiable factor linked to lower risk is significant for people over 40 and their eye care teams. The findings build on earlier research suggesting statins may have anti-inflammatory and nerve-protective effects, which could help explain the link.

This observational study analyzed patient data from more than 200,000 adults over 40 who took statins, compared against a control group of the same size. The results showed reduced glaucoma risk over 5 and 10 years and fewer procedures among glaucoma patients, but as an observational design it cannot establish cause and effect.

The players

British Journal of Ophthalmology

A peer-reviewed journal publishing research on eye health and disease, including glaucoma.

UC San Diego

The university where the senior study author works, home to major research in ophthalmology and vision science.

Life Biosciences

A biotechnology company developing epigenetic therapies, including one studied for protecting retinal ganglion cells in glaucoma patients.

The details

Statins lower cholesterol by inhibiting an enzyme the liver uses to make it, and researchers have proposed that they may also reduce inflammation and support the health of nerve cells. Glaucoma damages the optic nerve, often in connection with high pressure inside the eye, and cardiovascular factors such as high cholesterol, high blood pressure and diabetes are known to influence that risk. The researchers suggest statins could affect these pathways, though this mechanism has not been proven in glaucoma specifically.

Timeline

  1. Statin users' reduced glaucoma risk was measured over 5 years.

  2. Statin users' reduced glaucoma risk was measured over 10 years.

Health Landscape

Glaucoma is the number one cause of irreversible blindness worldwide, and current treatment centers on lowering eye pressure with drops, laser or surgery. Researchers are now exploring whether widely used cholesterol drugs and newer nerve-protective therapies such as those under study at Life Biosciences could add a preventive or complementary layer to that approach.

Adults over 40 may find it worth raising statin use and glaucoma risk with their eye doctor or primary care clinician, especially if they already have heart or cholesterol concerns. Routine eye exams remain the main way to catch glaucoma early, and anyone with questions about medication should discuss them with their physician rather than changing anything on their own.

The takeaway

Glaucoma often develops without symptoms, so regular eye exams matter even if the findings hold up. Ask your doctor whether your cholesterol management and eye care plan fit together well.

Further reading

For related context on how cholesterol-lowering drugs affect blood vessel health, explore our Stroke coverage.

Source note: This article includes information reported by Medscape.